Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | +1.43% | -1.28% | -38.34% |
04-17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
04-11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 74.81M 5.99B | Sales 2025 * | 164M 106M 8.51B | Capitalization | 334M 216M 17.34B |
---|---|---|---|---|---|
Net income 2024 * | -56M -36.33M -2.91B | Net income 2025 * | -17M -11.03M -883M | EV / Sales 2024 * | 2.72 x |
Net cash position 2024 * | 19.8M 12.84M 1.03B | Net cash position 2025 * | 1.85M 1.2M 96.34M | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
-6.17
x | P/E ratio 2025 * |
-31.2
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on AVITA Medical, Inc.
1 day | +1.43% | ||
1 week | -1.28% | ||
Current month | +0.71% | ||
1 month | -45.59% | ||
3 months | -51.74% | ||
6 months | -13.23% | ||
Current year | -38.34% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +1.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
01/05/24 | 8.49 | +1.07% | 4 764 |
30/04/24 | 8.4 | -3.67% | 145,172 |
29/04/24 | 8.72 | +2.35% | 189,868 |
26/04/24 | 8.52 | +2.65% | 285,980 |
25/04/24 | 8.3 | -3.15% | 251,806 |
Delayed Quote Nasdaq, May 01, 2024 at 02:46 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.34% | 217M | |
+0.26% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.91% | 24.63B | |
-24.16% | 18.2B | |
+26.81% | 12.01B | |
-3.46% | 11.76B | |
+9.93% | 10.4B | |
-1.62% | 9.94B |
- Stock Market
- Equities
- RCEL Stock